Pharmacovigilance and Drug Safety Software offers automated electronic submission capabilities, allowing teams to deliver regulatory safety reports directly to health authorities without delay.
The pharmacovigilance and drug safety software market was valued at US$ 1.97 billion in 2021 and is expected to reach US$ 3.29 billion by 2031. The market is expected to register a CAGR of 5.9% in...
